MAF1 and breast carcinoma: Compared to normal, MAF1 protein expression decreased in breast cancer patients aged 21–80, Fig 4B, with the most significant decrease in patients aged 41–60 yrs (p = 1.73 x 10−10) and 61–80 yrs (p = 6.34 x 10−10).